RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bristol-Myers Squibb Stock

Bristol-Myers Squibb P/E 2024

Bristol-Myers Squibb P/E

46.82

Ticker

BMY

ISIN

US1101221083

WKN

850501

As of Nov 21, 2024, Bristol-Myers Squibb's P/E ratio was 46.82, a 179.52% change from the 16.75 P/E ratio recorded in the previous year.

The Bristol-Myers Squibb P/E history

Bristol-Myers Squibb Aktienanalyse

What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide. Bristol-Myers Squibb ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Bristol-Myers Squibb's P/E Ratio

The Price to Earnings (P/E) Ratio of Bristol-Myers Squibb is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Bristol-Myers Squibb's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Bristol-Myers Squibb is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Bristol-Myers Squibb’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Bristol-Myers Squibb stock

What is the price-to-earnings ratio of Bristol-Myers Squibb?

The price-earnings ratio of Bristol-Myers Squibb is currently 46.82.

How has the price-earnings ratio of Bristol-Myers Squibb changed compared to last year?

The price-to-earnings ratio of Bristol-Myers Squibb has increased by 179.52% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Bristol-Myers Squibb high compared to other companies?

Yes, the price-to-earnings ratio of Bristol-Myers Squibb is high compared to other companies.

How does an increase in the price-earnings ratio of Bristol-Myers Squibb affect the company?

An increase in the price-earnings ratio of Bristol-Myers Squibb would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Bristol-Myers Squibb affect the company?

A decrease in the price-earnings ratio of Bristol-Myers Squibb would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Bristol-Myers Squibb?

Some factors that influence the price-earnings ratio of Bristol-Myers Squibb are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Bristol-Myers Squibb pay?

Over the past 12 months, Bristol-Myers Squibb paid a dividend of 2.28 USD . This corresponds to a dividend yield of about 3.94 %. For the coming 12 months, Bristol-Myers Squibb is expected to pay a dividend of 2.43 USD.

What is the dividend yield of Bristol-Myers Squibb?

The current dividend yield of Bristol-Myers Squibb is 3.94 %.

When does Bristol-Myers Squibb pay dividends?

Bristol-Myers Squibb pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of Bristol-Myers Squibb?

Bristol-Myers Squibb paid dividends every year for the past 26 years.

What is the dividend of Bristol-Myers Squibb?

For the upcoming 12 months, dividends amounting to 2.43 USD are expected. This corresponds to a dividend yield of 4.2 %.

In which sector is Bristol-Myers Squibb located?

Bristol-Myers Squibb is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bristol-Myers Squibb kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bristol-Myers Squibb from 11/1/2024 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Bristol-Myers Squibb pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Bristol-Myers Squibb in the year 2023?

In the year 2023, Bristol-Myers Squibb distributed 2.16 USD as dividends.

In which currency does Bristol-Myers Squibb pay out the dividend?

The dividends of Bristol-Myers Squibb are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bristol-Myers Squibb stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Bristol-Myers Squibb

Our stock analysis for Bristol-Myers Squibb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bristol-Myers Squibb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.